0000950170-24-003106.txt : 20240108 0000950170-24-003106.hdr.sgml : 20240108 20240108183234 ACCESSION NUMBER: 0000950170-24-003106 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240105 FILED AS OF DATE: 20240108 DATE AS OF CHANGE: 20240108 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Le-Nguyen Quoc CENTRAL INDEX KEY: 0001792062 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39122 FILM NUMBER: 24521365 MAIL ADDRESS: STREET 1: 535 MISSION STREET STREET 2: 14TH FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94105 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: 89bio, Inc. CENTRAL INDEX KEY: 0001785173 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 831114349 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 142 SANSOME STREET STREET 2: SECOND FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94104 BUSINESS PHONE: (415) 432-9270 MAIL ADDRESS: STREET 1: 142 SANSOME STREET STREET 2: SECOND FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94104 4 1 ownership.xml 4 X0508 4 2024-01-05 0001785173 89bio, Inc. ETNB 0001792062 Le-Nguyen Quoc C/O 89BIO, INC. 142 SANSOME STREET, 2ND FLOOR SAN FRANCISCO CA 94104 false true false false See Remarks false Common Stock 2024-01-05 4 A false 25000 0 A 188874 D Common Stock 2024-01-05 4 F false 9671 11.53 D 179203 D Represents settlement by the Issuer of performance-based restricted stock units ("RSUs") granted to the Reporting Person under the Company's Amended and Restated 2019 Equity Incentive Plan on September 9, 2022, which vested based on the Issuer's achievement of corporate performance objectives. These shares were withheld from the vesting of a performance-based RSU award to cover the estimated tax withholding obligation. Chief Technical Operations Officer and Head of Quality /s/ Ryan A. Murr, as attorney-in-fact for Quoc Le-Nguyen 2024-01-08